|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...2526272829303132333435...3940» |
- | Enrollment closed: Tobacco Dependence Treatment for Asian Americans (clinicaltrials.gov) - May 1, 2013
P2/3, N=164, Active, not recruiting, Sponsor: University of Massachusetts, Worcester
Recruiting --> Active, not recruiting
- Enrollment open: Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFT (clinicaltrials.gov) - Apr 29, 2013
P=N/A, N=336, Enrolling by invitation, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting Not yet recruiting --> Enrolling by invitation
- Enrollment change: Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients (clinicaltrials.gov) - Apr 28, 2013
P=N/A, N=100, Recruiting, Sponsor: IrisZorg
Not yet recruiting --> Enrolling by invitation N=80 --> 100
- citicoline / Generic mfg.
Enrollment change: Citicoline for Bipolar 1 Disorder and Cocaine Dependence (clinicaltrials.gov) - Apr 28, 2013
P4, N=130, Completed, Sponsor: University of Texas Southwestern Medical Center
N=80 --> 100 N=200 --> 130
- citicoline / Generic mfg.
Trial completion: Citicoline for Bipolar 1 Disorder and Cocaine Dependence (clinicaltrials.gov) - Apr 28, 2013
P4, N=130, Completed, Sponsor: University of Texas Southwestern Medical Center
N=200 --> 130 Active, not recruiting --> Completed
- New P1/2 trial: D-cycloserine (DCS) Pretreatment + CBT + Nicotine Replacement Therapy for Smoking Cessation (DCS) (clinicaltrials.gov) - Apr 25, 2013
P1/2, N=40, Recruiting, Sponsor: Mclean Hospital
- | GET 73 / CT Pharmaceutical Laboratory
New P1/2 trial: SPAD: Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent (clinicaltrials.gov) - Apr 25, 2013
P1/2, N=25, Not yet recruiting, Sponsor: Laboratorio Farmaceutico Ct S.r.l.
- Trial completion: The Effects of Nutritional Supplementation and Drug Abuse on HIV (clinicaltrials.gov) - Apr 25, 2013
P=N/A, N=878, Completed, Sponsor: Florida International University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Cesamet (nabilone) / Bausch Health, Viatris
Enrollment closed: Nabilone for Cannabis Dependence: A Pilot Study (clinicaltrials.gov) - Apr 24, 2013
P2/3, N=16, Active, not recruiting, Sponsor: Mclean Hospital
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial initiation date: Transcranial Direct Current Stimulation in a Smoking Cessation Trial (clinicaltrials.gov) - Apr 23, 2013
P2, N=66, Suspended, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Active, not recruiting Initiation date: Sep 2012 --> May 2013
- modafinil / Generic mfg.
Enrollment change: Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior (clinicaltrials.gov) - Apr 23, 2013
P2, N=94, Completed, Sponsor: Kyle Kampman
Initiation date: Sep 2012 --> May 2013 N=200 --> 94
- | Chantix (varenicline) / Pfizer
Trial completion: Tailoring Varenicline to Individual Needs (TVIN Study) (clinicaltrials.gov) - Apr 23, 2013
P3, N=200, Completed, Sponsor: Queen Mary University of London
N=200 --> 94 Recruiting --> Completed
- modafinil / Generic mfg.
Trial completion: Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior (clinicaltrials.gov) - Apr 23, 2013
P2, N=94, Completed, Sponsor: Kyle Kampman
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone (clinicaltrials.gov) - Apr 22, 2013
P3, N=150, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients (clinicaltrials.gov) - Apr 21, 2013
P4, N=30, Recruiting, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Behavioral Treatment for Substance Abuse (clinicaltrials.gov) - Apr 18, 2013
P1/2, N=38, Completed, Sponsor: University of Utah
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial termination: Oxytocin and Cognitive Behavioral Therapy in Drug Dependence (clinicaltrials.gov) - Apr 17, 2013
P4, N=310, Terminated, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed Recruiting --> Terminated
- benfotiamine / Generic mfg.
Enrollment change: B1AS: High Dose Vitamin B1 to Reduce Abusive Alcohol Use (clinicaltrials.gov) - Apr 17, 2013
P4, N=120, Completed, Sponsor: University of Kansas
Recruiting --> Terminated N=300 --> 120
- benfotiamine / Generic mfg.
Trial completion: B1AS: High Dose Vitamin B1 to Reduce Abusive Alcohol Use (clinicaltrials.gov) - Apr 17, 2013
P4, N=120, Completed, Sponsor: University of Kansas
N=300 --> 120 Active, not recruiting --> Completed
- Trial completion: Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use (clinicaltrials.gov) - Apr 17, 2013
P2, N=36, Completed, Sponsor: Boston University
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Group Therapy for Women Prisoners With Comorbid Substance Use and Depression (clinicaltrials.gov) - Apr 16, 2013
P2, N=38, Completed, Sponsor: Brown University
Recruiting --> Completed N=80 --> 38
- New P1 trial: Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders (clinicaltrials.gov) - Apr 16, 2013
P1, N=30, Recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
- Enrollment open: Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders (clinicaltrials.gov) - Apr 16, 2013
P1, N=30, Recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
N=80 --> 38 Not yet recruiting --> Recruiting
- Trial completion: Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis (clinicaltrials.gov) - Apr 16, 2013
P1, N=50, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial completion: VIDA: Validating Interventions for Diverse Adolescents (clinicaltrials.gov) - Apr 16, 2013
P2, N=70, Completed, Sponsor: Jason Burrow-Sanchez
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence (clinicaltrials.gov) - Apr 15, 2013
P3, N=21, Completed, Sponsor: Elizabeth Ralevski
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: A Brief Marijuana Intervention for Adolescent Women - 1 (clinicaltrials.gov) - Apr 14, 2013
P3, N=326, Completed, Sponsor: Butler Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- | buprenorphine/naloxone sublingual film / Generic mfg.
Enrollment change: Buprenorphine for Prisoners (clinicaltrials.gov) - Apr 11, 2013
P3, N=213, Completed, Sponsor: Friends Research Institute, Inc.
Recruiting --> Completed N=320 --> 213
- | buprenorphine/naloxone sublingual film / Generic mfg.
Trial completion: Buprenorphine for Prisoners (clinicaltrials.gov) - Apr 11, 2013
P3, N=213, Completed, Sponsor: Friends Research Institute, Inc.
N=320 --> 213 Recruiting --> Completed
- Clinical: Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=120, Recruiting, Sponsor: Centre for Addiction and Mental Health
- |||||||||| New P3 trial: To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure (clinicaltrials.gov) - Apr 9, 2013
P3, N=120, Not yet recruiting, Sponsor: Vital Therapies, Inc.
- modafinil / Generic mfg.
Trial completion: CAIMAN: Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction (clinicaltrials.gov) - Apr 9, 2013
P3, N=29, Completed, Sponsor: Assistance Publique - H
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Group Therapy for Women Prisoners With Comorbid Substance Use and Depression (clinicaltrials.gov) - Apr 8, 2013
P2, N=38, Completed, Sponsor: Brown University
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Ultra-brief Intervention for Problem Drinkers (clinicaltrials.gov) - Apr 7, 2013
P=N/A, N=1767, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Active, not recruiting --> Completed
- | Vycavert (10 mg hydrocodone bitartrate/325 mg acetaminophen) / Acura Pharma
Trial completion: Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users (clinicaltrials.gov) - Apr 6, 2013
P2, N=40, Completed, Sponsor: Acura Pharmaceuticals Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- oxytocin / Generic mfg.
Enrollment open: Oxytocin in Cocaine Dependence (clinicaltrials.gov) - Apr 3, 2013
P=N/A, N=152, Recruiting, Sponsor: Medical University of South Carolina
Recruiting --> Completed Not yet recruiting --> Recruiting
- Twinrix (inactivated hepatitis A and recombinant hepatitis B) / GSK
Trial completion: Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder (clinicaltrials.gov) - Apr 3, 2013
P2, N=236, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | New P2 trial: CIFFTA: Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial (clinicaltrials.gov) - Apr 2, 2013
P2, N=220, Recruiting, Sponsor: University of Miami
- Trial completion, Adherence: Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing (clinicaltrials.gov) - Apr 1, 2013
P=N/A, N=85, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open: TRAC: A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults (clinicaltrials.gov) - Mar 31, 2013
P=N/A, N=750, Recruiting, Sponsor: University of Pittsburgh
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: Treating Low-Income Smokers in the Hospital Emergency Department (clinicaltrials.gov) - Mar 28, 2013
P=N/A, N=778, Active, not recruiting, Sponsor: Yale University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion: Skills and Motivation at the Rhode Island Training School (Project SMART) - 1 (clinicaltrials.gov) - Mar 27, 2013
P2, N=205, Completed, Sponsor: University of Rhode Island
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Lucemyra (lofexidine) / US WorldMeds, Stada
New P1 trial: Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients (clinicaltrials.gov) - Mar 26, 2013
P1, N=30, Completed, Sponsor: US WorldMeds LLC
- Trial completion: The Effect of Yohimbine on Cocaine Cue Reactivity (clinicaltrials.gov) - Mar 26, 2013
P=N/A, N=113, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed Recruiting --> Completed
- Trial withdrawal: Preliminary Human Trial of NPI-028 (clinicaltrials.gov) - Mar 20, 2013
P2, N=0, Withdrawn, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting --> Completed Terminated --> Withdrawn
- Enrollment change: Preliminary Human Trial of NPI-028 (clinicaltrials.gov) - Mar 20, 2013
P2, N=0, Withdrawn, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Terminated --> Withdrawn N=160 --> 0
- Trial termination: Brain Glutamate Receptors and Cocaine Dependence (clinicaltrials.gov) - Mar 19, 2013
P=N/A, N=30, Terminated, Sponsor: National Institute on Drug Abuse (NIDA)
N=160 --> 0 Recruiting --> Terminated
- Enrollment change: Brain Glutamate Receptors and Cocaine Dependence (clinicaltrials.gov) - Mar 19, 2013
P=N/A, N=30, Terminated, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Terminated N=80 --> 30
- ||| Campral EC (acamprosate delayed release) / EMD Serono, Nippon Shinyaku
Enrollment change: Acamprosate: Genes Associated With Response (clinicaltrials.gov) - Mar 19, 2013
P4, N=485, Completed, Sponsor: Mayo Clinic
N=80 --> 30 N=200 --> 485
- Clinical: Contingency Management Treatment for Crack Addiction - Study With Brazilian Population (clinicaltrials.gov) - Mar 19, 2013
P=N/A, N=60, Recruiting, Sponsor: Federal University of São Paulo